The Health Canada has accepted for review EpiCept’s New Drug Submission (NDS) for Ceplene (histamine dihydrochloride) for the remission maintenance of acute myeloid leukemia (AML) patients in first
Huya Bioscience (Huya) has entered into a strategic partnership with the School of Medicine and Pharmacy, Ocean University of China. The agreement is an addition in a series
MorphoSys has received clearance from Germany’s Paul-Ehrlich-Institute as well as a positive opinion from the ethics committees in Germany to commence a Phase 1b/2a human clinical trial in
Daval International has received Orphan-Drug designation for its anti-inflammatory agent Aimspro for the treatment of amyotrophic lateral sclerosis (ALS) from the FDA. The company said that Aimspro has
Genmab has initiated a Phase III study of Arzerra ofatumumab plus chemotherapy versus rituximab plus chemotherapy to treat patients with relapsed or refractory diffuse large B-cell lymphoma (DLBCL).
Evotec has extended the research collaboration with Boehringer Ingelheim for a further 4 years, based on the success to date in the areas of CNS, inflammation, cardiometabolic and
Bend Research has entered into a collaboration with Vertex Pharmaceuticals (Vertex). Through the collaboration, Vertex will utilise Bend’s formulation development and manufacturing services for specific projects and clinical
As per the agreement, Vertex will utilise Bend’s formulation development and manufacturing services for specific projects and clinical trials, with the goals of both enhancing the delivery of
The acquisition of the manufacturing license will be effected through the acquisition of equity in Tianda as well as transfer of certain technologies from Tianda. Rosuvastatin was first
Halozyme (Halozyme) and ProMetic Life Sciences (ProMetic) have entered into a long-term supply agreement for a proprietary synthetic ligand affinity adsorbent manufactured by ProMetic’s UK subsidiary, ProMetic BioSciences.
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.